CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Denis Chem Lab Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Denis Chem Lab Ltd
Bl 457, Village Chhatral
Phone: +91 7926925716p:+91 7926925716 AHMEDABAD, 380015  India Ticker: 537536537536
Business Summary
Denis Chem Lab Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing pharmaceutical transfusion solutions in bottles. It offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. It manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The Company also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Dinesh B.Patel 87 4/25/2007 4/25/2007
Chief Executive Officer Nirmal H.Patel
Chief Financial Officer Vikram R.Joshi
6 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 13,876,668 (As of 9/30/2024)
Stock Exchange: BOM
Fax Number: +91 7926925710


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024